Thermo Fisher Scientific Applied Biosystems PureQuant Assays

Friday, 10 May, 2019 | Supplied by: Thermo Fisher Scientific



Applied Biosystems PureQuant Assays, from Thermo Fisher Scientific, are a family of assays that identify and quantify specific immune cell types in a mixed population of cells.

Designed for in-process and release testing of cell-based therapeutics, the assays measure genomic DNA methylation at sites that are unique to a specific immune cell type. With standards and controls built into each assay, they are ready to be seamlessly integrated into cell therapy workflows.

The assays’ core technology has been used for the identification and quantification of immune cell types for more than a decade. The qPCR method is easily standardised, enabling consistent results across multiple users, instruments and sites. The assays can be performed using fresh or frozen cells/gDNA, enabling flexibility.

The assays provide an innovative method for identity and purity testing of cell-based therapeutics, supporting cell therapy research, development and manufacturing. Regulatory support file is provided upon request, with established performance specifications following ICHQ2(R1) guidelines.

Online: www.thermofisher.com.au
Phone: 1300 735 292
Related Products

BioTek Instruments Scratch Assay Starter Kit

BioTek Instruments enhances cell biology workflows with the introduction of the Scratch Assay...

3Brain BioCAM DupleX bidirectional microelectrode array platform

The BioCAM DupleX, from 3Brain, is a fully bidirectional microelectrode array (also known as a...

AdipoGen Life Sciences APRIL ELISA Kit and BAFF ELISA Kit

AdipoGen Life Sciences has released ELISA kits for the specific quantitative determination of the...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd